Clinical Trial

Global Utilization And Registry Database for Improved preservAtion of doNor LUNGs

Study acronym: GUARDIANLUNG
Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
The objective of this registry is to collect and evaluate various clinical effectiveness parameters in patients with transplanted donor lung that were preserved and transported within the LUNGguard system, as well as retrospective standard of care patients
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2021-06-15; most recent amendment 2025-05-12.
Status change: Recruiting → Enrolling by Invitation 2022-08-09
Status change: Not Yet Recruiting → Recruiting 2021-09-24
Trial Details
NCT Number NCT04930289
Lead Sponsor Paragonix Technologies
Conditions Interstitial Lung Disease, COPD, Cystic Fibrosis, Pulmonary Fibrosis, Pulmonary Arterial Hypertension, Emphysema
Enrollment 2,000 participants
Start Date 2021-10-15
Primary Completion 2028-06-15 (estimated)
Study Completion 2029-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-05-15